Compare Revolution Medicines Inc. Common Stock (RVMD) vs Viasat (VSAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revolution Medicines Inc. Common Stock vs Viasat — how do they compare? Revolution Medicines Inc. Common Stock trades at $186.59 (market cap $40.32B), while Viasat trades at $73.06 (market cap $9.29B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 4.3× Viasat's market cap, and Revolution Medicines Inc. Common Stock is more actively traded (4,855,734 versus 2,084,105). Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Viasat for 10 Days on average.
| RVMD | VSAT | |
|---|---|---|
Market Cap | $40.32B | $9.29B |
Volume | 4,855,734 | 2,084,105 |
Sector | Health | Technology |
52-Week High | $221.15 | $89.81 |
52-Week Low | $47.50 | $30.35 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $37.02B | $14.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →About Viasat
Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.
Read more on VSAT →
